Versant Venture Capital
Venture capitalSan Francisco
Fund manager profile
Versant Venture Capital is a venture fund manager based in San Francisco. SEC filings show 4 venture funds on record, most recently Versant Venture Capital IX, L.P. ($600.4M offering) filed April 2023.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
What they invest in
from 4 of 5 portfolio companiesBiotech ×4Medical Devices ×1
HQs:United States×4
Investments · 5 tracked
founders shown can be your intro pathSan Diego, US
Board seatBradley J. BolzonClare Ozawa· per SEC Form D · $37.5M raise · filed Mar 2020
BiotechBasel
Kurt von Emster(Director)Sven Ante Lundberg(Executive Officer)Thomas Woiwode(Director)Ali Behbahani(Director)Rodger Novak(Executive Officer, Director)Pablo Cagnoni(Director)
Board seatBradley Bolzon· per SEC Form D · $35M raise · filed Nov 2016
BiotechSan Diego, US
Thomas Woiwode(Director)Bradley Bolzon(Director)Jerel Davis(Director)Petpiboon Prasit(Executive Officer, Director)Clare Ozawa(Executive Officer, Director)
Board seatBradley BolzonJerel DavisThomas Woiwode· per SEC Form D · $19.1M raise · filed Dec 2015
BiotechSouth San Francisco, US
Tim Anderson(Director)William Rieflin(Director)Aetna Wun Trombley(Executive Officer, Director)Laurent Fischer(Director)Ming Fang(Director)Amy Bachrodt(Executive Officer)
Board seatClare OzawaThomas Woiwode· per SEC Form D · $70.1M raise · filed Sep 2021
Santa Ana Bio develops engineered antibodies targeting immune system pathways to treat autoimmune and inflammatory diseases.
BiotechMedical DevicesAlameda, US
Peter Emtage(Founder & CEO)inAlexander Rudensky(Scientific Founder)Richard Flavell(Scientific Founder)Graham Lord(Scientific Founder)Ansuman Satpathy(Scientific Founder)Thomas Woiwode(Director)
Board seatJerel DavisThomas Woiwode· per SEC Form D · $70.3M raise · filed Feb 2023
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Fund performance · per public LP disclosures
as of Jun 2020| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| Versant Venture Capital I, L.P.LPs: The Regents of the University of California | 1999 | — | 10.2% | 2.02x | 2.02x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Frequently asked questions
- Where is Versant Venture Capital located?
- Versant Venture Capital is headquartered in San Francisco, US.